SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Preventive Visit — Lili Boulanger — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientLili Boulanger
Date of birth1893-08-21
IdentifiersMRN HR-ET025-SYN-TD; SSN (made up) 000-25-7731
Document date1915-10-19
AuthorOdile Marchetti-Rowe, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Adult preventive visit; no new complaints. [S]

History of Present Illness

Ms. Boulanger, now 22, returns for her yearly preventive visit. Her Crohn disease is in remission on risankizumab every eight weeks, with her last injection a week ago. The follow-up ileocolonoscopy two weeks ago showed healed ulcers (SES-CD 2). She has one or two formed stools a day, no pain, and has regained her weight. Her periods have become regular again. She is composing most mornings and has a new choral work in rehearsal. She completed the health risk assessment before the visit. [S]

ElementDetail
VisitAdult preventive visit, age 22
Active conditionsIleocolonic Crohn disease in remission on risankizumab
MedicinesRisankizumab 360 mg every 8 weeks; vitamin D3 1889 units daily
Recent eventsIleocolonoscopy two weeks ago: endoscopic response, SES-CD 2
Functional statusIndependent; composing and rehearsing

Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]

DomainFinding
Self-rated healthGood, better than at any time she can remember
PsychosocialSupportive friends and fellow musicians; feels safe at home; some worry about money from a year of reduced work
BehavioralNever smoker; no alcohol; no drugs; walks daily; eating three meals with snacks
Sexual and reproductive healthNot sexually active; no pregnancy plans for the next few years; contraception discussed
Activities of daily livingIndependent in all
Instrumental activities of daily livingManages her own medicines, injections, money, and household
Home safetySmoke detector working; wears a seat belt
SleepAbout eight hours a night

Review of Systems

SystemResultFinding
ConstitutionalNegativeWeight regained; no fever or night sweats
EyesNegativeNo red or painful eyes
Ears, nose, mouth, and throatNegativeNo mouth ulcers
CardiovascularNegativeNo chest pain or palpitations
RespiratoryNegativeNo cough
GastrointestinalNegativeOne or two formed stools a day; no pain or blood
GenitourinaryNegativeRegular periods; no urinary symptoms
MusculoskeletalNegativeNo joint pain or swelling
IntegumentaryNegativeNo rash, tender nodules, or new moles
NeurologicalNegativeNo headaches or numbness
PsychiatricNegativeMood good; PHQ-2 score 0

11 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, one or two tablets by mouth up to every 6 hours as needed for abdominal pain, no more than 3000 mg a day; no nonsteroidal anti-inflammatory drugsOne or two tablets up to every 6 hours as neededOral route1914-12-15activeS
Prednisone 20 mg oral tablet: 40 mg by mouth each morning, reduced by 5 mg each week over eight weeks, as a bridge until risankizumab takes effect40 mg each morning, tapering by 5 mg weeklyOral route1915-01-28 to 1915-03-24completedS
Risankizumab 600 mg in 10 mL intravenous infusion over at least one hour at weeks 0, 4, and 8 (induction)One infusion every 4 weeks for three dosesIntravenous route1915-02-02 to 1915-04-26completedS
Risankizumab 360 mg in 2.4 mL by subcutaneous on-body injector every 8 weeks (maintenance), from week 12One injection every 8 weeksSubcutaneous route1915-04-27activeS
Ferric derisomaltose 1000 mg in 10 mL intravenous infusion, single doseSingle infusionIntravenous route1915-02-02 to 1915-02-02completedS
Cholecalciferol (vitamin D3) 1889 units oral tablet, one tablet by mouth once dailyOne tablet once dailyOral route1915-01-28activeS
Calcium carbonate 1250 mg (500 mg elemental calcium) oral tablet, one tablet by mouth once daily with food while on prednisoneOne tablet daily with foodOral route1915-01-28 to 1915-03-24completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1915-10-19Body height160cmS
1915-10-19Body weight51.4kgS
1915-10-19Body mass index (BMI) [Ratio]20.1kg/m2S
1915-10-19Systolic blood pressure108mm[Hg]S
1915-10-19Diastolic blood pressure68mm[Hg]S
1915-10-19Heart rate70/minS
1915-10-19Respiratory rate14/minS
1915-10-19Body temperature36.6CelS
1915-10-19Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1915-10-19Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1915-10-19Total score [AUDIT-C]0{score}S

Physical Exam

Vital signs recorded on 1915-10-19; see the Vital Signs section. [S]

SystemFinding
ConstitutionalWell-appearing; BMI 20.1
EyesConjunctivae clear
MouthNo ulcers
NeckNo thyroid enlargement or nodes
CardiovascularRegular rhythm; no murmur
RespiratoryClear
AbdomenSoft, non-tender; no mass
SkinNo erythema nodosum; no suspicious lesions
MusculoskeletalNo joint swelling
PsychiatricBright and engaged

Problems

ProblemClinical statusVerificationCodeProvenance
Crohn disease of the terminal ileum and colon (ileocolitis), Montreal A2 L3 B1 without perianal disease, moderate to severe: deep ileal ulcers over 15 cm and patchy colonic ulcers, SES-CD 14, Harvey-Bradshaw Index 11; intestinal tuberculosis excluded by negative interferon-gamma release assay, normal chest X-ray, and biopsies negative for acid-fast bacilli, TB PCR, and mycobacterial culture; synthetic modern diagnosis linked to her documented chronic intestinal illness, whose historical diagnosis is not settledactiveconfirmed K50.80S — Synthetic diagnosis confirmed within the modern episode; her historical illness is documented (D), but whether it was intestinal tuberculosis or Crohn disease remains a retrospective interpretation (R) and is disputed.
Four months of crampy right lower abdominal pain, loose stools up to six times a day including at night, low-grade evening fevers, and loss of 6 kg; inflammatory markers raised; colonoscopy and small-bowel imaging bookedresolvedconfirmed R19.7S — Synthetic presenting concern at the index visit, superseded by the diagnosis; the documented symptoms of early 1915 are echoed (D).
Iron deficiency anemia from chronic intestinal blood loss and poor absorption (hemoglobin 10.6 g/dL, MCV 76, ferritin 9)resolvedconfirmed D50.0S — Synthetic finding at presentation; corrected by intravenous iron.
Moderate protein-calorie malnutrition: BMI 17.6 after losing 6 kg (12 percent of body weight) in four months; albumin 3.3 g/dLresolvedconfirmed E44.0S — Synthetic nutritional status at presentation; resolved with treatment and dietitian support.
Vitamin D deficiency (25-hydroxyvitamin D 18 ng/mL)resolvedconfirmed E55.9S — Synthetic finding at presentation.
Long-term use of risankizumab, an immunosuppressive biologic, for Crohn diseaseactiveconfirmed Z79.620S — Synthetic treatment status.
Acute norovirus gastroenteritis on risankizumab, with mild dehydration; distinguished from a Crohn flare by the sudden onset, household contacts, and a positive stool PCR; resolved in three daysresolvedconfirmed A08.11S — Synthetic common infection that teaches the difference between infection and a flare in treated Crohn disease; it does not echo a documented illness.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Influenza vaccine, 1915-1916Completed todayInactivated vaccine given today; recommended yearly on biologic therapy
COVID-19 vaccine, 1915-1916DueRecommended on immunosuppressive therapy; she will get it at her pharmacy next week
Pneumococcal vaccineUp to datePCV20 in January, before treatment; no further doses needed
Recombinant zoster vaccineUp to dateTwo doses completed, in January and April
Hepatitis B immunityUp to dateBooster in January; anti-HBs protective in April
HPV vaccineUp to dateSeries completed in adolescence
Tetanus boosterUp to dateTdap ten years ago at 12; next due now to within a year
Live vaccines (MMR, varicella)Not indicatedImmune by serology; live vaccines are avoided on risankizumab
Cervical cancer screeningCompleted todayFirst cervical cytology at 22, done today; women on immunosuppressive therapy may need closer screening, to be set by the result
Skin cancer preventionCompleted todaySun protection advised; skin examination today normal
Chlamydia and gonorrhea screeningNot indicatedNot sexually active; offered when that changes
HIV, hepatitis B, and hepatitis C screeningUp to dateNegative before treatment in January
Bone healthUp to dateDXA in January within the expected range; vitamin D now normal; no repeat needed unless more steroids are required
Depression and anxiety screeningCompleted todayPHQ-2 score 0
Unhealthy alcohol and drug use screeningCompleted todayAUDIT-C 0; no drug use
Tobacco useCompleted todayNever smoker; smoking worsens Crohn disease, and she was counseled never to start
Blood pressure screeningCompleted today108/68 mmHg
Physical activity and diet counselingCompleted todayDaily walking, a varied diet now that she is in remission, and calcium from food

Immunizations given today: Influenza vaccine, 1915-1916 season [S]

Guideline basis: ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol 2025;120:1447-1473 (2025); Adult Immunization Schedule by Medical Condition and Other Indication (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026)

Follow-up: Cervical cytology result by portal message. COVID-19 vaccine at her pharmacy. Next risankizumab dose in seven weeks. IBD review in four months. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 15 minutes, with her consent, prompted by a chronic illness treated with immunosuppression. She named a close friend as her health care agent and will complete a written health care directive at home. She would want full treatment for any serious illness from which she could expect to recover and return to composing. [S]